These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6410697)

  • 1. The glucose sensor. Some results and applications.
    Christensen SE; Schmitz O; Hansen AP; Orskov H
    Acta Med Scand Suppl; 1983; 671():121-8. PubMed ID: 6410697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control.
    Ward WK; Wood MD; Casey HM; Quinn MJ; Federiuk IF
    Artif Organs; 2005 Feb; 29(2):131-43. PubMed ID: 15670282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks].
    Sonnenberg GE; Spraul M; Chantelau EA; Berger M
    Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943
    [No Abstract]   [Full Text] [Related]  

  • 6. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
    Ibbini MS; Masadeh MA
    J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time glucose sensors in children and adolescents with type-1 diabetes.
    Danne T; Lange K; Kordonouri O
    Horm Res; 2008; 70(4):193-202. PubMed ID: 18772591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1988 May; 43(5):325-8. PubMed ID: 3042170
    [No Abstract]   [Full Text] [Related]  

  • 9. An artificial endocrine pancreas--problems awaiting solution for long-term clinical applications of a glucose sensor.
    Shichiri M; Fukushima H; Sakakida M; Kajiwara K; Hashiguchi Y
    Front Med Biol Eng; 1991; 3(4):283-92. PubMed ID: 1799562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the Biostator in optimizing insulin treatment (preliminary communication)].
    Kábrt J; Masek Z; Páv J
    Vnitr Lek; 1985 Sep; 31(9):870-6. PubMed ID: 4049764
    [No Abstract]   [Full Text] [Related]  

  • 11. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for insulin treatment with a portable insulin pump].
    Gutniak M; Johansson BL; Lager I; Lins PE; Nilsson A; Reichard P; Ostman J
    Lakartidningen; 1984 Nov; 81(48):4507-10. PubMed ID: 6521559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normoglycemic diabetic ketoacidosis in pregnancy.
    Chico M; Levine SN; Lewis DF
    J Perinatol; 2008 Apr; 28(4):310-2. PubMed ID: 18379571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensor-augmented pump therapy in type 1 diabetes.
    Weinzimer SA; Tamborlane WV
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):118-22. PubMed ID: 18316945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements.
    Hermanides J; Wentholt IM; Hart AA; Hoekstra JB; DeVries JH
    Diabetes Care; 2008 Jun; 31(6):1120-2. PubMed ID: 18332157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of artificial endocrine pancreas. From bedside-, wearable-type to implantable one.
    Shichiri M; Kawamori R; Yamasaki Y
    Med Prog Technol; 1987; 12(1-2):39-50. PubMed ID: 3627019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with using automated insulin infusion systems in diabetes mellitus type 1].
    Perelygina AA; Antsiferov MV; Starostina EG
    Sov Med; 1988; (5):72-5. PubMed ID: 3212534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.